A Micro-Immunotherapy Sequential Medicine MIM-seq Displays Immunomodulatory Effects on Human Macrophages and Anti-Tumor Properties towards In Vitro 2D and 3D Models of Colon Carcinoma and in an In Vivo Subcutaneous Xenograft Colon Carcinoma Model

In this study, the immunomodulatory effects of a sequential micro-immunotherapy medicine, referred as MIM-seq, were appraised in human primary M1 and M2 macrophages, in which the secretion of pro-inflammatory cytokines, such as interleukin (IL)-1β, IL-6, IL-12, IL-23, and tumor necrosis factor (TNF)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacques, Camille, Marchesi, Irene, Fiorentino, Francesco Paolo, Chatelais, Mathias, Lilli, Nicoletta Libera, Appel, Kurt, Lejeune, Beatrice, Floris, Ilaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181410/
https://www.ncbi.nlm.nih.gov/pubmed/35682738
http://dx.doi.org/10.3390/ijms23116059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181410/
https://www.ncbi.nlm.nih.gov/pubmed/35682738
http://dx.doi.org/10.3390/ijms23116059

Ejemplares similares